Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Blood-pressure Management in Off-pump CABG
NCT03629418Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of norepinephrine in acute kidney injury (AKI) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of acute kidney injury at 7 days. Started Aug 2018; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03629418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629418.